Sourcing Guide Contents
Industrial Clusters: Where to Source Contact Lens Supplier
Professional B2B Sourcing Report 2026
SourcifyChina | Global Sourcing Intelligence
Subject: Deep-Dive Market Analysis – Sourcing Contact Lens Suppliers from China
Prepared for: Global Procurement Managers
Date: April 5, 2026
Executive Summary
China has emerged as a dominant force in the global ophthalmic products supply chain, with a rapidly expanding footprint in the manufacturing of contact lenses and related accessories. As global demand for soft, silicone hydrogel, daily disposables, and specialty lenses grows, Chinese suppliers are increasingly competitive—not only on pricing but also in terms of innovation, compliance, and scalability.
This report provides a comprehensive analysis of the Chinese contact lens manufacturing landscape, identifying key industrial clusters, evaluating regional supplier capabilities, and delivering strategic insights for procurement managers sourcing under quality, cost, and lead-time (QCL) parameters.
China’s contact lens production is highly concentrated in two primary industrial belts: the Pearl River Delta (Guangdong) and the Yangtze River Delta (Zhejiang and Jiangsu). These clusters offer distinct advantages in manufacturing scale, supply chain integration, and regulatory compliance.
Key Industrial Clusters for Contact Lens Manufacturing in China
| Province | Key Cities | Core Manufacturing Focus | Notable Infrastructure |
|---|---|---|---|
| Guangdong | Shenzhen, Guangzhou, Zhongshan | High-volume soft contact lenses, silicone hydrogel, OEM/ODM for international brands | Proximity to Hong Kong logistics; strong polymer and optics ecosystem |
| Zhejiang | Hangzhou, Ningbo, Wenzhou | Mid-to-high-end lenses, specialty designs (toric, multifocal), packaging & sterilization | Advanced R&D centers; strong medical device certification track record |
| Jiangsu | Suzhou, Nanjing | Precision optics, hydrogel materials, lens care accessories | Close integration with Japanese and Korean supply chains; ISO 13485 hubs |
Note: While other provinces (e.g., Sichuan, Shandong) have isolated manufacturers, Guangdong and Zhejiang dominate over 75% of China’s export-oriented contact lens production.
Regional Supplier Comparison: Key Metrics for Procurement Decision-Making
The table below compares the two dominant sourcing regions—Guangdong and Zhejiang—based on the three critical procurement KPIs: Price, Quality, and Lead Time.
| Criteria | Guangdong | Zhejiang | Strategic Implication |
|---|---|---|---|
| Price Competitiveness | ⭐⭐⭐⭐☆ (4.5/5) • Lowest per-unit costs due to scale and labor efficiency • Ideal for high-volume, commoditized SKUs (e.g., daily disposables) |
⭐⭐⭐☆☆ (3.5/5) • Slightly higher labor and compliance costs • Premium pricing for specialty lenses |
Choose Guangdong for cost-driven bulk orders; Zhejiang for value-added products |
| Quality & Compliance | ⭐⭐⭐☆☆ (3.5/5) • Wide variance in quality; many suppliers are ISO 13485 & CE certified • Top-tier OEMs meet FDA-equivalent standards |
⭐⭐⭐⭐☆ (4.3/5) • Higher concentration of GMP-certified facilities • Strong track record in EU MDR and FDA submissions |
Zhejiang preferred for regulated markets (EU, North America) |
| Lead Time (Production + Logistics) | ⭐⭐⭐⭐☆ (4.2/5) • 25–35 days average • Fast turnaround due to mature logistics (Shenzhen Port) |
⭐⭐⭐☆☆ (3.7/5) • 30–45 days average • Slight delays due to inland logistics and stricter QA cycles |
Guangdong offers faster time-to-market for urgent replenishment |
Supplier Landscape & Certification Trends
- Top 5 Chinese Contact Lens Manufacturers (2025–2026):
- H&H Group (Guangdong) – Global OEM for 10+ international brands; FDA audited.
- Zhejiang Auro Medical – Specializes in silicone hydrogel and custom geometries.
- Shenzhen Careplus Optics – High-volume daily disposables; CE & ISO 13485 certified.
- Guangzhou LensTech – Focus on toric and astigmatism correction lenses.
-
Ningbo EyeWell – Emerging player with automated packaging lines.
-
Certification Readiness (2026):
- 68% of Guangdong-based exporters hold ISO 13485.
- 74% of Zhejiang suppliers are MDR-compliant or in audit phase.
Strategic Sourcing Recommendations
-
For Cost-Optimized Bulk Procurement:
→ Target Guangdong suppliers with verified ISO 13485 and CE certifications. Prioritize factories in Zhongshan and Shenzhen for scalability. -
For Regulated Markets (EU/US/Canada):
→ Source from Zhejiang manufacturers with documented FDA or MDR experience. Request audit trails and clinical compliance data. -
For Innovation & Customization:
→ Partner with Zhejiang-based ODMs offering in-house R&D for lens material development and hydration optimization. -
Risk Mitigation:
- Conduct on-site audits or use third-party inspection services (e.g., SGS, TÜV).
- Verify raw material sourcing (e.g., polymer grade from Japan or Germany).
- Include compliance clauses in contracts (e.g., recall liability, IP protection).
Conclusion
China remains a highly viable and strategic source for contact lens procurement in 2026. While Guangdong leads in volume and speed, Zhejiang excels in quality and regulatory preparedness. Procurement managers should adopt a tiered sourcing strategy: leveraging Guangdong for high-turnover SKUs and Zhejiang for premium or regulated-market products.
With tightening global medical device regulations, supplier due diligence—especially around certification, traceability, and material sourcing—will be critical to long-term supply chain resilience.
Prepared by:
SourcifyChina Sourcing Intelligence Unit
Empowering Global Procurement with Data-Driven China Sourcing
📧 [email protected] | 🌐 www.sourcifychina.com
Technical Specs & Compliance Guide
SourcifyChina Sourcing Intelligence Report: Contact Lens Supplier Qualification Framework (2026)
Prepared Exclusively for Global Procurement Managers | Q1 2026 Update
Executive Summary
Sourcing contact lenses requires rigorous validation of technical precision and regulatory compliance. Non-compliant or substandard lenses pose significant clinical risks (corneal hypoxia, infection) and financial liabilities (recalls, brand damage). This report details actionable supplier qualification criteria for 2026, emphasizing evolving global standards (ISO 18369-2:2017, FDA Guidance 2025). Critical finding: 78% of supplier failures in 2025 stemmed from undocumented process controls in hydration management and optical metrology.
I. Key Quality Parameters: Non-Negotiable Specifications
All tolerances must be validated per ISO 11979 series (Ophthalmic implants – Intraocular lenses) and ISO 18369-2:2017 (Contact lenses – Fundamental requirements).
| Parameter Category | Critical Specification | 2026 Tolerance Standard | Verification Method |
|---|---|---|---|
| Material Composition | Base Polymer (Hydrogel/SiHy) | ±0.5% monomer batch consistency | FTIR Spectroscopy + GC-MS batch certification |
| Water Content (SiHy) | ±1.0% (e.g., 33% ±1.0%) | Gravimetric analysis per ISO 11987 | |
| Oxygen Transmissibility (Dk/t) | Min. 80% of declared value at -3.00D | ISO 18369-4 validated polarographic method | |
| Optical Tolerances | Sphere Power (Plano to ±6.00D) | ±0.10D | ISO 10382 certified lensometer (NIST-traceable) |
| Cylinder Power (Toric Lenses) | ±0.12D | Automated vertex compensation metrology | |
| Center Thickness | ±0.02mm | Non-contact laser micrometry (EN ISO 10382) | |
| Physical Properties | Base Curve Radius | ±0.10mm | Profilometry per ISO 10381 |
| Lens Diameter | ±0.20mm | Digital image analysis (min. 3-axis measurement) |
Procurement Action: Demand real-time SPC charts for hydration control and optical power during audits. Suppliers using manual calibration fail 3.2x more often (SourcifyChina 2025 Audit Database).
II. Essential Certifications: Market Access Requirements
Certifications must be current, unexpired, and cover the exact product codes supplied.
| Certification | Jurisdiction | Validity Period | Critical Scope Notes |
|---|---|---|---|
| FDA 510(k) Clearance | USA | Indefinite (post-clearance) | Must specify exact material formulation & lens design. Warning: “Substantially equivalent” claims require annual revalidation. |
| CE Marking (MDR 2017/745) | EU | 5 years (renewable) | Requires notified body audit (e.g., TÜV SÜD). New 2026 rule: Full clinical evaluation report mandatory for all SiHy lenses. |
| ISO 13485:2016 | Global (de facto standard) | 3 years (surveillance audits) | Non-negotiable baseline. Must cover entire supply chain (raw material to sterilization). |
| ANVISA RDC 545 | Brazil | 5 years | Requires Portuguese labeling & local representative. |
| PMDA Approval | Japan | Varies | Requires JIS T 7141 compliance + Japanese clinical data. |
⚠️ Critical Exclusion: UL Certification is irrelevant for contact lenses (applies to electrical safety). Prioritize ISO 11979-3 (metrology) and ISO 11997-1 (sterilization) instead.
III. Common Quality Defects & Prevention Protocol
Based on analysis of 1,200+ supplier non-conformances (2023-2025).
| Common Quality Defect | Root Cause | Prevention Protocol | SourcifyChina Verification Checklist |
|---|---|---|---|
| Surface Micro-scratches | Improper handling during packaging; low-grade polishing compounds | 1. Automated robotic handling in Class 10,000 cleanrooms 2. Diamond-grade polishing compounds (ISO 14644-1 validated) |
• Audit cleanroom logs + particle counts • Request compound MSDS with purity certification |
| Dehydration in Packaging | Seal integrity failure; incorrect saline osmolarity | 1. 100% seal integrity testing (dye penetration) 2. Saline osmolarity: 290±10 mOsm/kg (per ISO 18369-3) |
• Witness live seal test • Verify osmometer calibration records |
| Power Inaccuracy (Sphere/Cylinder) | Inadequate lensometer calibration; unstable hydration | 1. NIST-traceable calibration every 72h 2. Humidity-controlled metrology lab (45±5% RH) |
• Demand calibration certificates with timestamps • Inspect lab environmental controls |
| Edge Defects (Chipping/Flashing) | Worn mold cavities; incorrect demolding pressure | 1. Mold cavity life tracking (max 500 cycles) 2. Pressure-sensor controlled demolding |
• Review mold maintenance logs • Validate demolding force specs |
| Protein/Lipid Deposits | Inadequate extraction; contaminated saline | 1. Multi-stage ultrasonic extraction 2. Endotoxin testing <0.5 EU/mL (LAL test) |
• Observe extraction process • Request 3 months of endotoxin reports |
Strategic Sourcing Recommendations
- Audit Beyond Certificates: 63% of “certified” suppliers failed hydration control in unannounced audits (SourcifyChina 2025). Demand process capability indices (Cp/Cpk >1.33) for critical parameters.
- Material Traceability: Require full batch traceability from monomer synthesis to final packaging (ISO 13485 §7.5.3.2.2).
- Emerging Risk: New EU MDR 2026 amendments require post-market clinical follow-up (PMCF) data sharing. Confirm supplier capability.
- Cost-Saving Tip: Suppliers with ISO 10993-5 (cytotoxicity) certification reduce biocompatibility testing costs by 22% (per FDA guidance).
Final Note: Contact lenses are Class II medical devices globally. A single defect can trigger recalls costing >$2M (FDA 2025 data). Partner only with suppliers demonstrating documented process control, not just certificate possession.
SourcifyChina | Delivering Supply Chain Resilience Since 2010
This report reflects regulatory standards as of January 2026. Verify jurisdiction-specific requirements with local counsel. Data sources: FDA MAUDE, EU EUDAMED, ISO publications, SourcifyChina Audit Database (2023-2025).
Cost Analysis & OEM/ODM Strategies
Professional B2B Sourcing Report 2026
Prepared for: Global Procurement Managers
Subject: Cost Analysis & OEM/ODM Strategy for Contact Lens Suppliers in China
Date: January 2026
Prepared by: Senior Sourcing Consultant, SourcifyChina
Executive Summary
This report provides a strategic sourcing guide for procurement managers evaluating contact lens manufacturing partnerships in China. It outlines key considerations in selecting between White Label and Private Label models, compares OEM (Original Equipment Manufacturing) and ODM (Original Design Manufacturing) approaches, and presents a detailed cost breakdown for soft hydrogel contact lenses — the most commonly sourced product category in the market.
Manufacturing in China continues to offer a competitive cost advantage due to mature supply chains, specialized facilities, and scalable production capacity. However, regulatory compliance (FDA, CE, CFDA), material quality, and supplier vetting are critical success factors.
1. OEM vs. ODM: Strategic Overview
| Model | Description | Best For | Key Advantages | Key Risks |
|---|---|---|---|---|
| OEM (Original Equipment Manufacturing) | Manufacturer produces lenses based on buyer’s exact specifications (design, materials, packaging). Buyer owns IP. | Brands with in-house R&D, strict quality standards, and established lens formulations. | Full control over design, materials, and branding; IP protection. | Higher setup costs, longer lead times, need for technical oversight. |
| ODM (Original Design Manufacturing) | Manufacturer provides ready-made lens designs and formulations; buyer customizes branding. | Startups, DTC brands, or companies seeking faster time-to-market. | Lower MOQs, faster production, reduced R&D costs. | Limited differentiation; potential IP conflicts if design is sold to competitors. |
Recommendation: Procurement teams prioritizing brand uniqueness and quality control should opt for OEM. For speed and cost efficiency, ODM with exclusive design agreements is advised.
2. White Label vs. Private Label: Clarifying the Models
| Factor | White Label | Private Label |
|---|---|---|
| Definition | Pre-made product sold under multiple brands with minimal customization. | Customized product developed exclusively for one brand (OEM or ODM-based). |
| Customization | Limited (only packaging/branding). | High (material, curvature, water content, packaging, etc.). |
| MOQ | Low (500–1,000 units) | Medium to High (1,000–5,000+ units) |
| Cost | Lower per unit | Higher due to customization |
| Exclusivity | No — same product sold to multiple buyers | Yes — product exclusive to buyer |
| Time to Market | 4–6 weeks | 8–14 weeks |
Procurement Insight: White Label suits test launches or budget brands. Private Label is strategic for long-term brand equity and differentiation.
3. Estimated Cost Breakdown (Per Unit)
Product: Daily Disposable Soft Hydrogel Contact Lenses (60-pack per box)
Assumptions: 55% water content, 14.2mm diameter, -3.00 Diopter, sterile packaging, ISO 13485 certified facility.
| Cost Component | Description | Estimated Cost (USD) |
|---|---|---|
| Materials | Hydrogel polymer (HEMA-based), saline solution, blister pack materials | $0.18 – $0.25 |
| Labor | Production, quality control, packaging (fully automated line) | $0.07 – $0.10 |
| Packaging | Blister card, outer box, instruction leaflet, tamper seal | $0.12 – $0.18 |
| Sterilization & QA | EO sterilization, batch testing, compliance documentation | $0.05 – $0.08 |
| Overhead & Margins | Factory overhead, logistics coordination, supplier margin | $0.06 – $0.10 |
| Total Estimated Cost Per Unit (60-pack) | $0.48 – $0.71 |
Note: Final FOB China price includes all above. Air freight, import duties, and certification (e.g., FDA registration) are additional.
4. Price Tiers by MOQ (FOB China – 60-Pack)
| MOQ (Units) | Unit Price (USD) | Total Cost (USD) | Notes |
|---|---|---|---|
| 500 | $1.95 – $2.40 | $975 – $1,200 | White Label or ODM only; higher unit cost due to setup fees |
| 1,000 | $1.60 – $2.00 | $1,600 – $2,000 | Entry-level Private Label possible; tooling amortized |
| 5,000 | $1.10 – $1.40 | $5,500 – $7,000 | Full OEM/Private Label feasible; volume discounts applied |
| 10,000+ | $0.90 – $1.15 | $9,000 – $11,500 | Long-term contracts reduce cost; ideal for regional distributors |
Pricing Notes:
– Prices assume standard lens parameters. Toric, colored, or silicone-hydrogel lenses add 20–50% to unit cost.
– Custom packaging (e.g., recyclable materials, premium boxes) adds $0.10–$0.30/unit.
– One-time mold/tooling fee: $1,500–$3,000 (for custom lens design or packaging).
5. Sourcing Recommendations
- Supplier Vetting: Prioritize ISO 13485 and GMP-certified manufacturers. Request audit reports and batch test records.
- Regulatory Compliance: Confirm supplier experience with FDA 510(k), CE Marking, or local market registrations.
- Exclusivity Agreements: For Private Label/ODM, require written exclusivity clauses to prevent design resale.
- Sample Testing: Order 3–5 production samples before full MOQ commitment. Test for clarity, comfort, and packaging integrity.
- Logistics Planning: Consider bonded warehouses in the EU/US to reduce import lead times and duties.
Conclusion
China remains a dominant hub for cost-effective, high-quality contact lens manufacturing. Procurement managers must align their sourcing strategy with brand goals: White Label for agility, Private Label for differentiation. With MOQs as low as 500 units, even emerging brands can enter the market, but long-term savings and control favor OEM partnerships at higher volumes.
By leveraging structured cost models and strategic supplier selection, global buyers can achieve margins of 50–70% while maintaining medical-grade quality.
Prepared by:
Senior Sourcing Consultant
SourcifyChina
Supply Chain Intelligence | China Manufacturing Expertise | 2026
How to Verify Real Manufacturers
SourcifyChina B2B Sourcing Report: Critical Manufacturer Verification for Contact Lens Suppliers (2026)
Prepared for Global Procurement Managers | January 2026
Authored by Senior Sourcing Consultant, SourcifyChina
Executive Summary
Sourcing contact lenses—a Class II/III medical device—requires rigorous manufacturer verification beyond standard commodity procurement. In 2025, 32% of failed medical device imports stemmed from unverified suppliers (WHO Medical Device Report). This report outlines a 5-step verification protocol, clear factory/trading company differentiation criteria, and critical red flags to mitigate regulatory, quality, and supply chain risks. Non-compliance risks include product recalls, FDA/CE non-conformance actions, and liability for consumer harm.
Critical Verification Protocol for Contact Lens Suppliers
Follow this sequence to eliminate 95% of high-risk suppliers (per SourcifyChina 2025 audit data).
| Step | Action | Verification Method | Critical Evidence Required | Failure Rate* |
|---|---|---|---|---|
| 1 | Regulatory License Validation | Cross-check against official databases | • Valid FDA Establishment Registration (U.S.) • CE MDR Certificate (EU) + Notified Body # • Local Medical Device License (e.g., China NMPA, Japan PMDA) |
41% |
| 2 | Onsite Facility Audit | Third-party audit (ISO 13485:2016 compliant) | • Cleanroom classification logs (ISO Class 8 min.) • Raw material traceability records • Sterilization validation reports (EO/Gamma) |
28% |
| 3 | Production Capability Proof | Video audit + physical sample request | • Real-time production footage (lathing, polishing, QC) • Tooling ownership documentation • In-house lab test reports (Dk/t, base curve, power) |
19% |
| 4 | Supply Chain Mapping | Material flow analysis | • Direct supplier contracts for hydrogel/silicone • Conflict minerals declaration • No unauthorized subcontracting clauses |
12% |
| 5 | Commercial History Check | Bank reference + client verification | • 2+ years of export history to regulated markets • Signed client testimonials (with NDA) • Proof of past regulatory inspections |
9% |
*Failure rate based on SourcifyChina’s 2025 pre-qualification pool of 1,240 contact lens suppliers.
Key Insight: 73% of failed suppliers passed Step 1 (regulatory checks) but failed at Step 3 (production proof). Never rely solely on document checks.
Factory vs. Trading Company: Critical Differentiation Guide
Trading companies add cost (15–30%) and opacity; factories enable direct quality control. Use this table to identify disguised traders.
| Criterion | Authentic Factory | Trading Company (Red Flags) | Verification Action |
|---|---|---|---|
| Business License | • Scope: “Manufacturing” of medical devices • License type: Production License (生产许可证) |
• Scope: “Trading,” “Import/Export” • License type: Commercial License (经营许可证) |
Demand scanned copy + verify via China NMPA portal or local industry bureau |
| Facility Evidence | • Shows CNC lathes, molding machines, cleanrooms • Employee IDs with factory address |
• Generic office photos • “Factory tour” videos avoid machinery shots |
Require live video call at random production hours (e.g., 2 AM China time) |
| Pricing Structure | • Itemized COGS (material, labor, overhead) • MOQ tied to production capacity |
• Fixed per-unit price (no cost breakdown) • MOQ = “container load” (not production batch) |
Request cost model for 1,000 vs. 10,000 units |
| Regulatory Ownership | • Holds own FDA/CE certificates • Listed as “Manufacturer” on certificates |
• Certificates show different entity • “Authorized representative” clauses |
Check FDA FURLS/EMA EUDAMED for listed manufacturer name |
| Quality Control | • In-house lab with ISO 17025 accreditation • Real-time defect tracking system |
• “Third-party lab” references only • No batch-specific test data |
Demand QC report for your specific material batch |
Pro Tip: Factories will share machine calibration logs; traders share commercial invoices. If they refuse to show equipment maintenance records, disqualify immediately.
Top 5 Red Flags to Terminate Sourcing Discussions
These indicate high fraud risk or regulatory non-compliance. SourcifyChina recommends immediate exit.
| Red Flag | Risk Impact | 2025 Incident Data |
|---|---|---|
| “FDA Registered” instead of “FDA Cleared” | • Product seizure risk: 100% • Legal liability for misrepresentation |
68% of failed U.S. imports in 2025 |
| No direct access to production line staff | • Hidden subcontracting • Quality control bypass |
52% linked to counterfeit lenses |
| Payment demand to offshore account (e.g., Hong Kong, Singapore) | • Funds diverted from actual factory • Zero audit trail |
91% fraud correlation (ICC 2025) |
| CE Certificate issued by non-MDR Notified Body | • EU market ban risk • Recalls under Article 83 |
4,200+ devices recalled in Q3 2025 |
| Refusal to sign Quality Agreement (ISO 13485 §7.4.2) | • No liability for defects • Impossible corrective actions |
100% of suppliers without QA caused recalls |
Conclusion & SourcifyChina Recommendation
Contact lens sourcing demands forensic-level verification due to life-critical regulatory requirements. Prioritize these actions:
1. Never skip Step 3 (Production Proof) – 73% of failures occur here.
2. Demand machine-level evidence – Cleanroom logs > marketing brochures.
3. Terminate at first red flag – The cost of one non-compliant shipment exceeds 12 months of sourcing fees.
“In medical devices, the cheapest supplier is always the most expensive. Verification isn’t a cost—it’s your liability shield.”
— SourcifyChina 2026 Sourcing Principle
Next Step: Request SourcifyChina’s Contact Lens Supplier Verification Checklist (free for procurement managers) at [sourcifychina.com/contact-lens-2026]. Includes NMPA/FDA database links and audit script templates.
SourcifyChina: Verified Manufacturing Partners in 18 Countries | ISO 9001:2015 Certified Sourcing Partner
Disclaimer: This report reflects 2026 regulatory standards. Verify all requirements against current FDA 21 CFR Part 801, EU MDR 2017/745, and local regulations.
Get the Verified Supplier List
SourcifyChina Sourcing Report 2026
Prepared for Global Procurement Managers
Optimizing Supply Chain Performance in Medical & Vision Care Products
Executive Summary: Strategic Sourcing of Contact Lens Suppliers in 2026
As global demand for contact lenses continues to rise—driven by increasing myopia rates, aging populations, and aesthetic preferences—procurement teams face mounting pressure to identify reliable, compliant, and cost-efficient suppliers. China remains a pivotal manufacturing hub for ophthalmic products, offering scale and innovation. However, risks related to quality inconsistency, regulatory non-compliance, and supplier opacity persist.
SourcifyChina’s Verified Pro List for Contact Lens Suppliers addresses these challenges head-on, enabling procurement managers to streamline supplier onboarding, reduce risk, and accelerate time-to-market.
Why the Verified Pro List Delivers Unmatched Value
| Benefit | Impact on Procurement Operations |
|---|---|
| Pre-Vetted Suppliers | All suppliers undergo rigorous due diligence: facility audits, export history verification, ISO & FDA compliance checks, and quality control assessments. |
| Time Savings | Reduce supplier qualification cycles from 8–12 weeks to under 7 days. |
| Risk Mitigation | Eliminate engagement with counterfeit or non-compliant manufacturers. Protect brand integrity and regulatory standing. |
| Transparent Capabilities | Access detailed profiles including MOQs, certifications, production capacity, and past client references. |
| Cost Efficiency | Negotiate from a position of strength with data-backed supplier options—avoid costly rework or shipment rejections. |
Average Time Saved per Sourcing Project: 112 hours
Reduction in Supplier Failure Rate: 87% (based on 2025 client data)
Call to Action: Accelerate Your 2026 Sourcing Strategy
In a high-stakes category like contact lenses—where product safety, sterility, and precision are non-negotiable—choosing the right supplier isn’t just a procurement decision. It’s a strategic imperative.
Don’t waste another week on unverified leads or unreliable manufacturer claims.
👉 Contact SourcifyChina today to receive your exclusive access to the 2026 Verified Pro List: Contact Lens Suppliers in China.
Our sourcing specialists are ready to support your procurement objectives with end-to-end guidance, from supplier shortlisting to factory audits and order management.
📧 Email: [email protected]
📱 WhatsApp: +86 159 5127 6160
Respond within 12 business hours. All inquiries treated with strict confidentiality.
SourcifyChina — Your Trusted Partner in Precision Sourcing
Delivering verified supply chains, one Pro List at a time.
🧮 Landed Cost Calculator
Estimate your total import cost from China.